- Home
- TMCI vs BGB Comparison
TMCI vs BGB Comparison
Compare TMCI & BGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMCI
- BGB
- Stock Information
- Founded
- TMCI 2014
- BGB 2012
- Country
- TMCI United States
- BGB United States
- Employees
- TMCI N/A
- BGB N/A
- Industry
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BGB Trusts Except Educational Religious and Charitable
- Sector
- TMCI Health Care
- BGB Finance
- Exchange
- TMCI Nasdaq
- BGB Nasdaq
- Market Cap
- TMCI 460.5M
- BGB 538.2M
- IPO Year
- TMCI 2021
- BGB N/A
- Fundamental
- Price
- TMCI $5.74
- BGB $11.94
- Analyst Decision
- TMCI Hold
- BGB
- Analyst Count
- TMCI 6
- BGB 0
- Target Price
- TMCI $9.18
- BGB N/A
- AVG Volume (30 Days)
- TMCI 554.1K
- BGB 154.6K
- Earning Date
- TMCI 05-08-2025
- BGB 01-01-0001
- Dividend Yield
- TMCI N/A
- BGB 9.75%
- EPS Growth
- TMCI N/A
- BGB N/A
- EPS
- TMCI N/A
- BGB N/A
- Revenue
- TMCI $210,819,000.00
- BGB N/A
- Revenue This Year
- TMCI $10.61
- BGB N/A
- Revenue Next Year
- TMCI $10.36
- BGB N/A
- P/E Ratio
- TMCI N/A
- BGB N/A
- Revenue Growth
- TMCI 7.54
- BGB N/A
- 52 Week Low
- TMCI $4.54
- BGB $10.40
- 52 Week High
- TMCI $10.79
- BGB $11.97
- Technical
- Relative Strength Index (RSI)
- TMCI 30.94
- BGB 56.38
- Support Level
- TMCI $5.70
- BGB $11.78
- Resistance Level
- TMCI $6.20
- BGB $11.93
- Average True Range (ATR)
- TMCI 0.37
- BGB 0.10
- MACD
- TMCI -0.08
- BGB -0.00
- Stochastic Oscillator
- TMCI 2.04
- BGB 74.47
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
About BGB Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest
Blackstone Strategic Credit Fund is a closed-end term fund. Its primary investment objective is to seek high current income. The secondary objective of the fund is to seek the preservation of capital. Under normal market conditions, the Fund invests at least 80% of its Managed Assets in senior, secured floating-rate loans. The fund also invest in second-lien loans and high yield bonds and employs financial leverage, which may increase risk to the Fund. The Fund has a limited term and absent shareholder approval to extend the life of the Fund.